Modulation of oxidative stability of haemoglobin inside liposome-encapsulated haemoglobin

被引:4
|
作者
Awasthi, Vibhudutta [1 ]
Yadav, Vivek R. [1 ]
Goins, Beth [2 ]
Phillips, William T. [2 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Oklahoma City, OK 73117 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol, San Antonio, TX 78229 USA
基金
美国国家卫生研究院;
关键词
haemoglobin; transfusion; methaemoglobin; oxygen carriers; liposomes; catalase; BLOOD SUBSTITUTES; OXYGEN CARRIER; TRANSFUSION MEDICINE; FUTURE GENERATIONS; CELL; METHEMOGLOBIN; RESUSCITATION; POLYHEMOGLOBIN; REDUCTION; VESICLES;
D O I
10.3109/02652048.2012.752535
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The major hurdle in the formulation of liposome-encapsulated haemoglobin (LEH) is the oxidation of haemoglobin (Hb) into methaemoglobin during storage and after administration. In order to reduce this oxidative degradation, we tested various reducing conditions in the presence of catalase. We found that at 37 degrees C more than 50% of Hb oxidized to methaemoglobin within 24 h, whereas in presence of catalase, the oxidation was significantly reduced. The effect of catalase was further enhanced by a reduction mixture containing beta-NAD, d-glucose, adenine, inosine, MgCl2, KCl, KH2PO4 and Na2HPO4; only 14% methaemoglobin was generated in the presence of catalase and reduction mixture. Contrary to the expectation, glutathione, deferoxamine and homocysteine enhanced Hb oxidation. The presence of CRM inside liposomes (250 nm) significantly decreased Hb oxidation. The results suggest that catalase and a well-defined mixture of co-factors may help control Hb oxidation for improvement in the functional life of LEH.
引用
收藏
页码:470 / 478
页数:9
相关论文
共 50 条
  • [21] Optimization of selected liposome-encapsulated diketopiperazines
    Kilian, G.
    Milne, P.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2014, 24 (02) : 143 - 147
  • [22] LIPOSOME-ENCAPSULATED HEMOGLOBIN PROCESSING METHODS
    ZHENG, SM
    ZHENG, YM
    BEISSINGER, RL
    FRESCO, R
    BIOMATERIALS ARTIFICIAL CELLS AND IMMOBILIZATION BIOTECHNOLOGY, 1992, 20 (2-4): : 355 - 364
  • [23] TARGETING HIV WITH LIPOSOME-ENCAPSULATED ANTIVIRALS
    DESORMEAUX, A
    BERGERON, MG
    ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES, 1995, 282 (03): : 225 - 231
  • [24] USE OF LIPOSOME-ENCAPSULATED DRUGS IN LEISHMANIASIS
    ALVING, CR
    STECK, EA
    TRENDS IN BIOCHEMICAL SCIENCES, 1979, 4 (08) : N175 - N177
  • [25] EXAFS study of liposome-encapsulated cisplatin
    Arcon, I
    Kodre, A
    Abra, RM
    Huang, A
    Vallner, JJ
    Lasic, DD
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2004, 33 (3-4) : 199 - 204
  • [26] DELIVERY OF LIPOSOME-ENCAPSULATED DRUGS TO MACROPHAGES
    ALVING, CR
    PHARMACOLOGY & THERAPEUTICS, 1983, 22 (03) : 407 - 424
  • [27] LIPOSOME-ENCAPSULATED DTPA IN PLUTONIUM THERAPY
    ROSENTHAL, MW
    RAHMAN, YE
    RADIATION RESEARCH, 1974, 59 (01) : 134 - 134
  • [28] Liposome-encapsulated midazolam for oral administration
    Tomoyasu, Yumiko
    Yasuda, Tatsuji
    Maeda, Shigeru
    Higuchi, Hitoshi
    Miyawaki, Takuya
    JOURNAL OF LIPOSOME RESEARCH, 2011, 21 (02) : 166 - 172
  • [29] Topical anesthesia of liposome-encapsulated tetracaine
    Hung, OR
    Comeau, L
    Riley, M
    Tan, S
    Whynot, S
    Mezei, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PI9 - PI9
  • [30] Distribution of liposome-encapsulated antimony in dogs
    Schettini, DA
    Val, APC
    Souza, LF
    Demicheli, C
    Rocha, OGI
    Melo, MN
    Michalick, MSM
    Frézard, F
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2003, 36 (02) : 269 - 272